OBI Pharma Sponsors Successful Adagloxad Simolenin (OBI-822) Symposium at ESMO

OBI Pharma is pleased to provide video highlights from the successful company-sponsored symposium that took place at the 2016 European Society for Medical Oncology (ESMO) Annual Meeting in Copenhagen, Denmark, on Monday, October 10, 2016. The symposium, “Novel Approaches to Active Immunotherapy in Oncology – Targeting Globo Series with Adagloxad Simolenin”, reviewed the data on […]